X

Drug Profile

Research programme: chemokine antagonists - NeoRx

Alternative Names: Chemotides

Latest Information Update: 08 Dec 2003

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Poniard Pharmaceuticals
Class Small molecules
Mechanism of Action Chemokine receptor antagonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

Discontinued Asthma; Inflammation

Most Recent Events

08 Dec 2003 Discontinued - Preclinical for Asthma in USA (unspecified route)
08 Dec 2003 Discontinued - Preclinical for Inflammation in USA (unspecified route)
14 Aug 2001 No-Development-Reported for Asthma in USA (Unknown route)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com